PUBLICATIONS DES MEMBRES

Ovarian epithelial dysplasia after ovulation induction : time and dose effects
2009 - Chene G,Penault-Llorca F,Le-Bouedec G,Mishellany F,Dauplat MM,Tardieu AS,Pomel C,Jaffeux P,Aublet-Cuvelier B,Pouly JL,Dechelotte P,Dauplat J Hum Reprod n°24 - pp 132-8
Ovarian epithelial dysplasia and prophylatic oophorectomy for genetic risk
2009 - Chene G,Penault-Llorca F,Le-Bouedec G,Mishellany F,Dauplat MM,Jaffeux P,Aublet-Cuvelier B,Pouly JL,Dechelotte P,Dauplat J Int J Gynecol Cancer n°19 - pp 65-72
Peritoneal carcinosis in ovarian cancer: conventional imaging (CT-scan and MRI)
2009 - Bailly C,Bailly-Glatre A,Alfidja A,Vincent C,Dauplat J,Pomel C Bull Cancer n°96 - pp 1155-62
Personalized and predictive medicine in Turkey : a symposium report of Istanbul Working Group on personalized medicine,Istanbul,Turkey
2009 - Hizel C,Gok S,Sardas S,Bernard-Gallon DJ,Maugard C,Genc E Curr Pharm and Perso Med n°7 - pp 297-301
Phase II trial of the association of a methionine-free diet with cystemustine therapy in melanoma and glioma
2009 - Thivat E,Farges MC,Bacin F,D-Incan M,Mouret-Reynier MA,Cellarier E,Madelmont JC,Vasson MP,Chollet P,Durando X Anticancer Res n°29 - pp 5235-40
Place of autologous and allogeneic hematopoietic stem cell transplantation in ovarian cancer
2009 - Nayl B,Cabrespine A,Maliki Y,Bay JO Bull Cancer n°96 - pp 1225-32
Prognostic factors in early-stage leiomyosarcoma of the uterus
2009 - Pelmus M,Penault-Llorca F,Guillou L,Collin F,Bertrand G,Trassard M,Leroux A,Floquet A,Stoeckle E,Thomas L,MacGrogan G Int J Gynecol Cancer n°19 - pp 385-90
Rad50 c.687delT does not contribute significantly to familial breast cancer in a French population
2009 - Uhrhammer N,Delort L,Bignon YJ Cancer Epidem Biomark Prev n°18 - pp 684-5
Role of neo-adjuvant hormonal therapy in the treatment of breast cancer: a review of clinical trials
2009 - Abrial C,Durando X,Mouret-Reynier MA,Thivat E,Bayet-Robert M,Nayl B,Dubray P,Pomel C,Chollet P,Penault-Llorca F Int J Gen med n°2 - pp 129-40
SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome
2009 - Probst V,Wilde AA,Barc J,Sacher F,Babuty D,Mabo P,Mansourati J,Le-Scouarnec S,Kyndt F,Le-Caignec C,Guicheney P,Gouas L,Albuisson J,Meregalli PG,Le-Marec H,Tan HL,Schott JJ Circ Cardiovasc Genet n°2 - pp 522-7
Strong correlation between VEGF and MCL-1 mRNA expression levels in B-cell chronic lymphocytic leukemia
2009 - Veronese L,Tournilhac O,Verrelle P,Davi F,Dighiero G,Chautard E,Veyrat-Masson R,Kwiatkowski F,Goumy C,Gouas L,Bay JO,Vago P,Tchirkov A Leukemia n°3 - pp 1623-6
Targeted radionuclide therapy of melanoma: anti-tumoural efficacy studies of a new 131I labelled potential agent
2009 - Bonnet-Duquennoy M,Papon J,Mishellany F,Labarre P,Guerquin-Kern JL,Wu TD,Gardette M,Maublant J,Penault-Llorca F,Miot-Noirault E,Cayre A,Madelmont JC,Chezal JM,Moins N Int J Cancer n°125 - pp 708-16
The "weight" of words on the forearms during relaxation
2009 - Santarpia A,Blanchet A,Mininni G,Kwiatkowski F,Lindeman L,Lambert JF Appl Psychophysiol Biofeedback n°34 - pp 105-11
Trastuzumab for patients with axillary-node-positive breast cancer: results of the FNCLCC-PACS 04 trial
2009 - Spielmann M,Roche H,Delozier T,Canon JL,Romieu G,Bourgeois H,Extra JM,Serin D,Kerbrat P,Machiels JP,Lortholary A,Orfeuvre H,Campone M,Hardy-Bessard AC,Coudert B,Maerevoet M,Piot G,Kramar A,Martin AL,Penault-Llorca F J Clin Oncol n°27 - pp 6129-34
Use of gene expression profiles of peripheral blood lymphocytes to distinguish BRCA1 mutation carriers in high risk breast cancer families
2009 - Vuillaume ML,Uhrhammer N,Vidal V,Vidal VS,Chabaud V,Jesson B,Kwiatkowski F,Bignon YJ Cancer Inform n°7 - pp 41-56
Validation de l'échelle d'évaluation du risque suicidaire RSD après tentative de suicide chez 330 patients hospitalisés dans un service d'urgence
2009 - Ducher JL,Kwiatkowski F,Dupuy C,Mangeon JP,Feral A,Schmidt J,Llorca PM Journal de Thérapie Comportementale et cognitive n°19 - pp 47-52
Value and limitations of measuring HER-2 extracellular domain in the serum of breast cancer patients
2009 - Leary AF,Hanna WM,Van-De-Vijver MJ,Penault-Llorca F,Ruschoff J,Osamura RY,Bilous M,Dowsett M J Clin Oncol n°27 - pp 1694-705
A new prognostic classification after primary chemotherapy for breast cancer: residual disease in breast and nodes (RDBN)
2008 - Chollet P,Abrial C,Durando X,Thivat E,Tacca O,Mouret-Reynier MA,LeHeurteur M,Kwiatkowski F,Dauplat J,Penault-Llorca F cancer J n°14 - pp 128-32
Absence of Olig 2 mutations in patients presenting with a severe Pelizaus-Merzbacher-like leukodistrophy associated with motor neurone dysfunction
2008 - Bonnet-Dupeyron MN,Combes P,Boespflug-Tanguy O,Vaurs-Barriere C Am J Med Genet Part B n°147B - pp 538-9
Adiponectin and leptin expression in primary ductal breast cancer and in adjacent healthy epithelial and myoepithelial tissue
2008 - Jarde T,Caldefie-Chezet F,Damez M,Mishellany F,Penault-Llorca F,Guillot J,Vasson MP Histopathology n°53 - pp 484-7